Skip to content
10-Q

Quarterly Report

UNITED THERAPEUTICS Corp UTHR

0001628280-25-036541

← back to feed
Filed
Jul 30, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 23, 2025 45.23M sh
Shares Diluted Q2 2025 · Jun 30, 2025 48.3M sh
Shares Diluted Q2 2025 · Jun 30, 2025 48.5M sh
Shares Diluted Q2 2025 · Jun 30, 2024 47.5M sh
Shares Diluted Q2 2025 · Jun 30, 2024 48.6M sh
Stock Repurchased Q2 2025 · Jun 30, 2025 $0
Stock Repurchased Q2 2025 · Jun 30, 2024 $1B
Capex Q2 2025 · Jun 30, 2025 $137.1M
Capex Q2 2025 · Jun 30, 2024 $83.3M
Operating Cash Flow Q2 2025 · Jun 30, 2025 $652.9M
Operating Cash Flow Q2 2025 · Jun 30, 2024 $608.7M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $1.59B
Cash And Equivalents Q2 2025 · Dec 31, 2024 $1.7B
Stockholders Equity Q2 2025 · Jun 30, 2025 $7.17B
Stockholders Equity Q2 2025 · Mar 31, 2025 $6.81B
Stockholders Equity Q2 2025 · Dec 31, 2024 $6.44B
Stockholders Equity Q2 2025 · Jun 30, 2024 $5.7B
Stockholders Equity Q2 2025 · Mar 31, 2024 $5.34B
Stockholders Equity Q2 2025 · Dec 31, 2023 $5.98B
Current Liabilities Q2 2025 · Jun 30, 2025 $527.1M
Current Liabilities Q2 2025 · Dec 31, 2024 $738.1M
Total Liabilities Q2 2025 · Jun 30, 2025 $734.4M
Total Liabilities Q2 2025 · Dec 31, 2024 $920M
Current Assets Q2 2025 · Jun 30, 2025 $3.83B
Current Assets Q2 2025 · Dec 31, 2024 $3.87B
Total Assets Q2 2025 · Jun 30, 2025 $7.91B
Total Assets Q2 2025 · Dec 31, 2024 $7.36B
Eps Diluted Q2 2025 · Jun 30, 2025 $6.41
Eps Diluted Q2 2025 · Jun 30, 2025 $13.02
Eps Diluted Q2 2025 · Jun 30, 2024 $5.85
Eps Diluted Q2 2025 · Jun 30, 2024 $12.03
Eps Basic Q2 2025 · Jun 30, 2025 $6.86
Eps Basic Q2 2025 · Jun 30, 2025 $14.04
Eps Basic Q2 2025 · Jun 30, 2024 $6.26
Eps Basic Q2 2025 · Jun 30, 2024 $12.79
Sga Expense Q2 2025 · Jun 30, 2025 $212.5M
Sga Expense Q2 2025 · Jun 30, 2025 $382.6M
Sga Expense Q2 2025 · Jun 30, 2024 $177.6M
Sga Expense Q2 2025 · Jun 30, 2024 $322M
Rd Expense Q2 2025 · Jun 30, 2025 $134M
Rd Expense Q2 2025 · Jun 30, 2025 $283M
Rd Expense Q2 2025 · Jun 30, 2024 $139.6M
Rd Expense Q2 2025 · Jun 30, 2024 $243.7M
Net Income Q2 2025 · Jun 30, 2025 $309.5M
Net Income Q2 2025 · Jun 30, 2025 $631.7M
Net Income Q2 2025 · Jun 30, 2024 $278.1M
Net Income Q2 2025 · Jun 30, 2024 $584.7M
Operating Income Q2 2025 · Jun 30, 2025 $364.5M
Operating Income Q2 2025 · Jun 30, 2025 $747.3M
Operating Income Q2 2025 · Jun 30, 2024 $319.9M
Operating Income Q2 2025 · Jun 30, 2024 $676.2M
Gross Profit Q2 2025 · Jun 30, 2025 $711M
Gross Profit Q2 2025 · Jun 30, 2025 $1.41B
Gross Profit Q2 2025 · Jun 30, 2024 $637.1M
Gross Profit Q2 2025 · Jun 30, 2024 $1.24B
Cost Of Revenue Q2 2025 · Jun 30, 2025 $87.6M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $180.1M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $77.8M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $150.7M
Revenue Q2 2025 · Jun 30, 2025 $798.6M
Revenue Q2 2025 · Jun 30, 2025 $1.59B
Revenue Q2 2025 · Jun 30, 2024 $714.9M
Revenue Q2 2025 · Jun 30, 2024 $1.39B